MainSleaze

This spammer is an old acquaintance here. They’re still spamming through Benchmark, who haven’t reacted to the previous post. This one was brought to their attention in an abuse complaint as well. This post is Part 1 in a series of two; OMICS are using multiple channels to spam.

Spamming IP: 38.107.205.4

Spam headers:

Return-Path: <bounce@bmsend.com>
Received: from benchmarkmails4.com (benchmarkmails4.com [38.107.205.4])
        by x (Postfix) with ESMTP id x
        for <x>; Tue, 20 Mar 2012 16:1x:xx +0200 (EET)
Received: from benchmarkmails4.com (benchmarkmails4.com [127.0.0.1])
        by benchmarkmails4.com (Postfix) with ESMTP id x
        for <x>; Tue, 20 Mar 2012 05:4x:xx -0400 (EDT)
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed; d=omicsonline.bmsend.com; h=
        reply-to:list-unsubscribe:from:sender:to:subject:date
        :mime-version:content-type; s=bmdeda; bh=rNEovTg+rP2+lKIDyLhIFOE
        XD8k=; b=cetGEzXpw15z7Ipxm36Y3Bo3PKQfSifVhZZ8rWt5Pe3zCaLoPktQAly
        dhf6EL6oYCZuHHSkwN/C9viKjmr6pjnl/lme3vaYuL7g9BpgHf9XxBIhDCiBx+fq
        usZ40p1DLmA2HvLfUnC048kmO7dWk6rI6kPgt4Wa3HxHLKY4IZDU=
DomainKey-Signature: a=rsa-sha1; c=nofws; d=omicsonline.bmsend.com; h=
        reply-to:list-unsubscribe:from:sender:to:subject:date
        :mime-version:content-type; q=dns; s=bmdeda; b=K9rr6PODwHCKX15je
        u4G4TmlbZF+vSE44qo0hWp9lstS5jg9uJW63CCJLNxih/SJuaFtYU81bIiA4NN1j
        bmLKUURmX8OMhyN4VvoklcCbfVoMAxDsAnWddkxZrmKMWZDlXBYnL9edkHyCh5bz
        pMihi5ASqjmVH5rjtvtoa7LBD4=
Reply-To: editor.jcst@omicsgroup.com
X-Identify: <x_x@bmsend.com>
X-Mailer: 6, 5, 0, 3
X-campaignid: x
MimeOLE: <Produced By Microsoft MimeOLE V6.00.2800.1165>
RemoveEmail: unsubscribe.asp?g=0&c=x&l=x&e=x&ver=2&SentFromServer=38.107.205.4
SentFromServer: 38.107.205.4
Message-Info: <x+x>
List-Unsubscribe: <http://www.benchmarkemail.com/c/u?x%2Fx%2Bx%3D>
From: OMICS Publishing Group <editor.jcst@omicsgroup.com>
Sender: OMICS Publishing Group <editor.jcst@omicsonline.bmsend.com>
To: x <x>
Subject: Call for Papers Invitation: Cancer Science & Therapy - Open Access
Date: Tue, 20 Mar 2012 10:1x:xx -0400
MIME-Version: 1.0
Content-Type: multipart/alternative;
        boundary="----=_NextPart_x"

Human-readable spam content:

Having trouble viewing this email? click here: http://viewpage.benchmarkemail.com/c/v?e=x&c=x&l=x&email=x%2Fx&relid=x

You are receiving this email because of your relationship with OMICS Publishing Group. Please reconfirm your interest in receiving email from us.  If you do not wish to receive any more emails, you can unsubscribe here
Confirm URL :http://www.benchmarkemail.com/c/opt?e=x&c=x&l=x&email=x%2Fx&relid=x
JCST

CFP:[1] Journal of Cancer Science & Therapy- [2] Open Access

Guaranteed 21-days rapid review process.

Dear X,

We are writing to you in our capacity as the editors of the [3] Journal of Cancer Science & Therapy, an open-access and peer-reviewed journal.

Journal of Cancer Science & Therapy publishes original research, review papers including but not limited to following fields.

Cancer Therapy

Cancer Bio-Informatics

Advances in Cancer Detection and Imaging

Carcinogenesis

Cancer Cell Biology

Cancer Stem Cells

Diagnostic and Prognostic Cancer Biomarkers

Molecular Cancers

Organ Specific Cancers

Anti Cancer Drugs

Why with us

User Friendly/feasible website translation of your paper to worlds leading languages (if interested)

21 Day rapid review process

Publication within 7 days of acceptance

Quality and quick editorial, review processing

Key features

Free PDF/Digital file of your published paper

No restriction for use/distribution

Create great looking digital files for distribution

Sharing your published work in social networking like face book, twitter, LinkedIn, RSS feeds etc

Our comprehensive team helps you to distribute your published paper

Electronic submission of manuscripts is strongly encouraged. Online manuscript submission, review and tracking systems of Editorial Manager for quality and quick review processing. Immediate publication tentatively within a month/two months of Initial submission. JCST using OMICS Group Editorial Manager® for quality reviewing process.

Submit manuscript at [4] http://www.editorialmanager.com/cancerscience/

(OR) by e-mail to editor.jcst@omicsonline.org

Please visit :[5] http://www.omicsonline.org/jcsthome.phpfor instructions and world quality editorial board members.

OMICS Group is organizing more than 50 conferences all over the world in 2012-2013. We recommend your presence in any OMICS Group conference, for more details PS: [6] http://www.omicsonline.org/conferencemain

Please visit for our other relevant journals : [7] http://omicsonline.org/Journals.php

Best regards,

Editors-[8] Journal of Cancer Science & Therapy

Prof. Harvey I. Pass

NYU Langone Medical Center, USA

Prof. William E. Grizzle

University of Alabama, USA

Prof. Peter E. Barker

National Institute of Standards and Technology, USA

Prof. Mong-Hong Lee

University of Texas, USA

Prof. Ajay Rana

Loyola University, USA

Prof. Kenneth Maiese

University of Medicine & Dentistry, USA

Prof. Lily Yang

Emory University, USA

Prof. Sridhar Mani

Albert Einstein College of Medicine, USA

Prof. Vincent L. Wilson

Louisiana State University, USA

Prof. Masato Yamamoto

University of Minnesota, USA

Editorial office

5716 Corsa Ave., Suite 110

Westlake, Los Angeles, CA 91362-7354, USA

E-Mail:editor.jcst@omicsonline.org

Phone: +1-650-268-9744

Fax: +1-650-618-1414

Toll free : +1-800-216-6499

OMICS Publishing Group is the member of/publishing partner of/source content provider to

[9] CrossRef
[10] PubMed
[11] DOAJ
[12] Index Copernicus
[13] Scientific Commons

All Published content, except where otherwise noted, is licensed under [14] Creative Commons Attribution License.

This is not a spam message, and has been sent to you because of your eminence in the field. If, however, you do not want to receive any email in future from Journal of Cancer Science & Therapy, then please reply with remove/unsubscribe.

References:

1. http://omicsonline.org/jcsthome.php
2. http://omicsonline.org/jcsthome.php
3. http://omicsonline.org/jcsthome.php
4. http://www.editorialmanager.com/cancerscience/
5. http://www.omicsonline.org/jcsthome.php
6. http://www.omicsonline.org/conferencemain
7. http://omicsonline.org/Journals.php
8. http://www.omicsonline.org/EditorialboardJCST.php
8. http://www.omicsonline.org/EditorialboardJCST.php
9. http://www.crossref.org/index.html
10. http://www.pubmedcentral.nih.gov/
11. http://www.doaj.org/doaj?func=home
12. http://publishers.indexcopernicus.com/index.php
13. http://en.scientificcommons.org
14. http://creativecommons.org/licenses/by/2.0/

This message was sent to x by editor.jcst@omicsgroup.com

You can modify/update your subscription via the link below.

Unsubscribe from all mailings
http://www.benchmarkemail.com/c/su?e=x&c=x&l=x&email=x%2Fx&relid=x

Manage Subscription
http://www.benchmarkemail.com/c/s?e=x&c=x&l=x&email=x%2Fx&relid=x

Forward Email
http://www.benchmarkemail.com/c/f?e=x&c=x&l=x&email=x%2Fx&relid=x
Report Abuse
http://www.benchmarkemail.com/Abuse?e=x&c=x&l=x&email=x%2Fx&relid=x

Email Marketing
BenchmarkEmail.com
[http://www.benchmarkemail.com]

USA